Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Recommendations for diagnosis and management of multiple sclerosis.
Painful Tonic Spasm in Neuromyelitis Optica: Incidence, Diagnostic Utility, and Clinical Characteristics.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
T cell-intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis.
Novartis updates US label on Gilenya® following discussions with the FDA
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
The natural course of clinically isolated syndrome in pediatric patients.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
Central nervous system lymphoma associated with natalizumab.
[Cannabinoid drugs for neurological diseases: what is behind?].
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.
IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats.
Functional role of TRP channels in modulating ER stress and Autophagy.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
New Drug Review 2010: Ustekinumab (Stelara, Centocor Ortho Biotech)
An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.
Autoimmunity: Rubbing salt in the wound.
Pages
« first
‹ previous
…
170
171
172
173
174
175
176
177
178
…
next ›
last »